ABEO Logo

Abeona Therapeutics Inc. (ABEO) 

NASDAQ$5.29
Market Cap
$229.96M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
264 of 924
Rank in Industry
151 of 527

ABEO Insider Trading Activity

ABEO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$154,036556
Sells
$275,137444

Related Transactions

Alland Leiladirector1$51,7990$0$51,799
Seshadri VishwasChief Executive Officer1$32,0000$0$32,000
O'Malley Brendan M.SVP, General Counsel1$27,8640$0$27,864
Charles Faith L.director1$24,7640$0$24,764
Vazzano Joseph WalterChief Financial Officer1$17,6090$0$17,609
Silverstein Christine Bernidirector0$01$116,453$-116,453
Alvino Markdirector0$03$158,684$-158,684

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye â€¦

Insider Activity of Abeona Therapeutics Inc.

Over the last 12 months, insiders at Abeona Therapeutics Inc. have bought $154,036 and sold $275,137 worth of Abeona Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Abeona Therapeutics Inc. have bought $134,796 and sold $1.08M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Alland Leila (director) — $51,799. Seshadri Vishwas (Chief Executive Officer) — $32,000. O'Malley Brendan M. (SVP, General Counsel) — $27,864.

The last purchase of 11,000 shares for transaction amount of $51,799 was made by Alland Leila (director) on 2024‑05‑16.

List of Insider Buy and Sell Transactions, Abeona Therapeutics Inc.

2025-01-29SaleAlvino Markdirector
4,000
0.0092%
$5.38$21,520+0.92%
2025-01-21SaleAlvino Markdirector
4,000
0.0091%
$5.10$20,400+5.01%
2024-06-18SaleSilverstein Christine Bernidirector
25,821
0.0635%
$4.51$116,453+23.68%
2024-06-18SaleAlvino Markdirector
25,890
0.0637%
$4.51$116,764+23.68%
2024-05-16PurchaseAlland Leiladirector
11,000
0.0286%
$4.71$51,799+20.76%
2024-04-26PurchaseCharles Faith L.director
7,550
0.0265%
$3.28$24,764+68.71%
2024-04-25PurchaseSeshadri VishwasChief Executive Officer
10,000
0.0343%
$3.20$32,000+72.41%
2024-04-25PurchaseVazzano Joseph WalterChief Financial Officer
5,608
0.0189%
$3.14$17,609+72.41%
2024-04-25PurchaseO'Malley Brendan M.SVP, General Counsel
8,600
0.0299%
$3.24$27,864+72.41%
2024-02-06PurchaseSeshadri VishwasChief Executive Officer
20,000
0.0784%
$4.39$87,800+32.33%
2024-01-17SaleAlvino Markdirector
7,084
0.0285%
$5.11$36,199+9.53%
2023-09-27SaleAmoroso Michaeldirector
5,508
0.022%
$3.91$21,542+21.97%
2023-09-27SaleSilverstein Christine Bernidirector
6,330
0.0252%
$3.91$24,721+21.97%
2023-09-27SaleAlland Leiladirector
7,246
0.0288%
$3.90$28,270+21.97%
2023-09-27SaleCharles Faith L.director
8,330
0.0417%
$4.91$40,924+21.97%
2023-09-27SaleAlvino Markdirector
6,316
0.0252%
$3.91$24,724+21.97%
2023-09-27PurchaseSeshadri VishwasChief Executive Officer
20,000
0.083%
$4.07$81,400+21.97%
2023-09-20SaleAmoroso Michaeldirector
327
0.0014%
$3.90$1,275+25.79%
2023-09-19PurchaseVazzano Joseph WalterChief Financial Officer
3,000
0.0122%
$3.82$11,458+26.12%
2023-09-18PurchaseO'Malley Brendan M.SVP, General Counsel
3,000
0.0125%
$3.80$11,400+30.25%
Total: 103
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Seshadri VishwasChief Executive Officer
538260
1.2382%
$2.85M30+27.15%
Vazzano Joseph WalterChief Financial Officer
233868
0.538%
$1.24M30+3.41%
O'Malley Brendan M.SVP, General Counsel
188718
0.4341%
$998,318.2245+5.36%
Alland Leiladirector
82857
0.1906%
$438,313.5311
Charles Faith L.director
78323
0.1802%
$414,328.6711
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$21,574,635
88
2.81%
$217.93M
$7,150,333
87
-8.28%
$207.01M
$69,130,029
69
25.63%
$240.78M
$11,468,215
44
17.78%
$246.73M
$48,218,096
42
0.89%
$204.72M

ABEO Institutional Investors: Active Positions

Increased Positions31+54.39%3M+9.82%
Decreased Positions18-31.58%941,288-3.27%
New Positions15New572,147New
Sold Out Positions4Sold Out63,983Sold Out
Total Postitions70+22.81%31M+6.55%

ABEO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Adage Capital Partners Gp, L.L.C.$20,448.009.07%3.9M+652,366+20.07%2024-12-31
Suvretta Capital Management, Llc$19,312.008.57%3.69M00%2024-12-31
Nantahala Capital Management, Llc$18,493.008.21%3.53M+96,577+2.81%2024-12-31
Millennium Management Llc$11,094.004.92%2.12M-184,459-8.01%2024-12-31
Western Standard Llc$10,922.004.85%2.08M+386,321+22.75%2024-12-31
Vanguard Group Inc$10,302.004.57%1.97M-41,603-2.07%2024-12-31
Vivo Capital, Llc$9,656.004.29%1.84M00%2024-12-31
Rosalind Advisors, Inc.$9,460.004.2%1.81M-26,610-1.45%2024-12-31
Laurion Capital Management Lp$6,847.003.04%1.31M00%2024-12-31
683 Capital Management, Llc$4,149.001.84%791,845+116,845+17.31%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.